AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $4.2M invested in AIM ImmunoTech in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$164K
2
+$82.2K
3
+$9K

Top Sellers

1
-$102K
2
-$68K
3
-$36K
4
VKH
Virtu KCG Holdings
New York
-$22K
5
Northern Trust
Northern Trust
Illinois
-$18.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.48M
2
$1.4M
3
$707K
4
$240K
5
$86K
6
$74K
7
$52K
8
$35K
9
$28K
10
$25K
11
$21K
12
$12K
13
$9K
14
$9K
15
$9K
16
$5K
17
$5K
18
$3K
19
$3K
20
$3K
21
$1K
22
–
23
–